(1) Olsson, T. S. G.; Williams, M. a.; Pitt, W. R.; Ladbury, J. E. The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design. J. Mol. Biol.2008, 384 (4), 1002–1017.
(2) Fox, J. M.; Zhao, M.; Fink, M. J.; Kang, K.; Whitesides, G. M. The Molecular Origin of Enthalpy/Entropy Compensation in Biomolecular Recognition. Annu. Rev. Biophys.2018, 47.
(3) Mobley, D. L.; Gilson, M. K. Predicting Binding Free Energies: Frontiers and Benchmarks. Annu. Rev. Biophys.2017, 46, 531–558.
(4) Hert, J.; Irwin, J. J.; Laggner, C.; Keiser, M. J.; Shoichet, B. K. Quantifying Biogenic Bias in Screening Libraries. Nat. Chem. Biol.2009, 5, pages479–483.
(5) Smanski, M. J.; Zhou, H.; Claesen, J.; Shen, B.; Fischbach, M. A.; Voigt, C. A. Synthetic Biology to Access and Expand Nature’s Chemical Diversity. Nature Reviews Microbiology. 2016, pp 135–149.
(6) Fürstenberg-Hägg, J.; Zagrobelny, M.; Bak, S. Plant Defense against Insect Herbivores. Int. J. Mol. Sci.2013, 14 (5), 10242–10297.
(7) Maier, M. E. Design and Synthesis of Analogues of Natural Products. Organic and Biomolecular Chemistry. Royal Society of Chemistry May 2015, pp 5302–5343.
(8) Chen, M. S.; White, M. C. A Predictably Selective Aliphatic C-H Oxidation Reaction for Complex Molecule Synthesis. Science (80-. ).2007, 318 (5851), 783–787.
(9) Atanasov, A. G.; Waltenberger, B.; Pferschy-Wenzig, E. M.; Linder, T.; Wawrosch, C.; Uhrin, P.; Temml, V.; Wang, L.; Schwaiger, S.; Heiss, E. H.; et al. A Historical Overview of Natural Products in Drug Discovery. Metabolites. 2012, pp 1582–1614.
(10) Paul, S. M.; Mytelka, D. S.; Dunwiddie, C. T.; Persinger, C. C.; Munos, B. H.; Lindborg, S. R.; Schacht, A. L. How to Improve RD Productivity: The Pharmaceutical Industry’s Grand Challenge. Nature Reviews Drug Discovery. Nature Publishing Group March 2010, pp 203–214.
(11) Li, J. W. H.; Vederas, J. C. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? Science. July 2009, pp 161–165.
(12) Jensen, P. R.; Chavarria, K. L.; Fenical, W.; Moore, B. S.; Ziemert, N. Challenges and Triumphs to Genomics-Based Natural Product Discovery. J. Ind. Microbiol. Biotechnol.2014, 41 (2), 203–209.
(13) Medema, M. H.; Blin, K.; Cimermancic, P.; De Jager, V.; Zakrzewski, P.; Fischbach, M. A.; Weber, T.; Takano, E.; Breitling, R. AntiSMASH: Rapid Identification, Annotation and Analysis of Secondary Metabolite Biosynthesis Gene Clusters in Bacterial and Fungal Genome Sequences. Nucleic Acids Res.2011, 39 (suppl_2), W339–W346.
(14) Jensen, P. R. Natural Products and the Gene Cluster Revolution. Trends Microbiol.2016, 24, 968–977.
(15) Yan, Y.; Liu, Q.; Zang, X.; Yuan, S.; Bat-Erdene, U.; Nguyen, C.; Gan, J.; Zhou, J.; Jacobsen, S. E.; Tang, Y. Resistance-Gene-Directed Discovery of a Natural-Product Herbicide with a New Mode of Action. Nature2018, 559, 415–418.
(16) Culp, E. J.; Waglechner, N.; Wang, W.; Fiebig-Comyn, A. A.; Hsu, Y. P.; Koteva, K.; Sychantha, D.; Coombes, B. K.; Van Nieuwenhze, M. S.; Brun, Y. V.; et al. Evolution-Guided Discovery of Antibiotics That Inhibit Peptidoglycan Remodelling. Nature2020, 578 (7796), 582–587.
(17) Zhabinskii, V. N.; Khripach, N. B.; Khripach, V. A. Steroid Plant Hormones: Effects Outside Plant Kingdom. Steroids. Elsevier Inc. 2015, pp 87–97.
(18) Li, Y.; Li, S.; Thodey, K.; Trenchard, I.; Cravens, A.; Smolke, C. D. Complete Biosynthesis of Noscapine and Halogenated Alkaloids in Yeast. Proc. Natl. Acad. Sci. U. S. A.2018, 115 (17), E3922–E3931.
(19) Luo, X.; Reiter, M. A.; D’Espaux, L.; Wong, J.; Denby, C. M.; Lechner, A.; Zhang, Y.; Grzybowski, A. T.; Harth, S.; Lin, W.; et al. Complete Biosynthesis of Cannabinoids and Their Unnatural Analogues in Yeast. Nature2019, 567, 123–126.
(20) He, R.; Yu, Z.; Zhang, R.; Zhang, Z. Protein Tyrosine Phosphatases as Potential Therapeutic Targets. Acta Pharmacol. Sin.2014, 35 (10), 1227–1246.
(21) Paul, M. K.; Mukhopadhyay, A. K. Tyrosine Kinase – Role and Significance in Cancer. Int. J. Med. Sci.2012, 1 (2), 101–115.
(22) Ferguson, F. M.; Gray, N. S. Kinase Inhibitors: The Road Ahead. Nature Reviews Drug Discovery. 2018, pp 353–376.
(23) Stanford, S. M.; Bottini, N. Targeting Tyrosine Phosphatases: Time to End the Stigma. Trends in Pharmacological Sciences. 2017, pp 524–540.
(24) Krishnan, N.; Koveal, D.; Miller, D. H.; Xue, B.; Akshinthala, S. D.; Kragelj, J.; Jensen, M. R.; Gauss, C.-M.; Page, R.; Blackledge, M.; et al. Targeting the Disordered C Terminus of PTP1B with an Allosteric Inhibitor. Nat. Chem. Biol.2014, 10 (7), 558–566.
(25) Barr, A. J.; Ugochukwu, E.; Lee, W. H.; King, O. N. F.; Filippakopoulos, P.; Alfano, I.; Savitsky, P.; Burgess-Brown, N. A.; Müller, S.; Knapp, S. Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome. Cell2009, 136 (2), 352–363.
(26) Banno, R.; Zimmer, D.; De Jonghe, B. C.; Atienza, M.; Rak, K.; Yang, W.; Bence, K. K. PTP1B and SHP2 in POMC Neurons Reciprocally Regulate Energy Balance in Mice. J. Clin. Invest.2010, 120 (3), 720–734.
(27) Zabolotny, J. M.; Kim, Y. B.; Welsh, L. A.; Kershaw, E. E.; Neel, B. G.; Kahn, B. B. Protein-Tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo. J. Biol. Chem.2008, 283 (21), 14230–14241.
(28) Matulka, K.; Lin, H. H.; Hříbková, H.; Uwanogho, D.; Dvořák, P.; Sun, Y. M. PTP1B Is an Effector of Activin Signaling and Regulates Neural Specification of Embryonic Stem Cells. Cell Stem Cell2013, 13 (6), 706–719.
(29) Zhang, H.; Wang, Y.; Wu, J.; Skalina, K.; Pfeifer, B. A. Complete Biosynthesis of Erythromycin A and Designed Analogs Using E. Coli as a Heterologous Host. Chem. Biol.2010, 17 (11), 1232–1240.
(30) Antosch, J.; Schaefers, F.; Gulder, T. A. M. Heterologous Reconstitution of Ikarugamycin Biosynthesis in E. Coli. Angew. Chemie Int. Ed.2014, 53 (11), 3011–3014.
(31) Montalibet, J.; Kennedy, B. P. Using Yeast to Screen for Inhibitors of Protein Tyrosine Phosphatase 1B. Biochem. Pharmacol.2004, 68 (9), 1807–1814.
(32) Piserchio, A.; Cowburn, D.; Ghose, R. Expression and Purification of Src-Family Kinases for Solution NMR Studies. Methods Mol. Biol.2012, 831, 111–131.
(33) Badran, A. H.; Guzov, V. M.; Huai, Q.; Kemp, M. M.; Vishwanath, P.; Kain, W.; Nance, A. M.; Evdokimov, A.; Moshiri, F.; Turner, K. H.; et al. Continuous Evolution of Bacillus Thuringiensis Toxins Overcomes Insect Resistance. Nature2016, 533 (7601), 58–63.
(34) Kaneko, T.; Huang, H.; Cao, X.; Li, X.; Li, C.; Voss, C.; Sidhu, S. S.; Li, S. S. C. C. Superbinder SH2 Domains Act as Antagonists of Cell Signaling. Sci. Signal.2012, 5 (243), ra68–ra68.
(35) Jiang, C. S.; Liang, L. F.; Guo, Y. W. Natural Products Possessing Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitory Activity Found in the Last Decades. Acta Pharmacol. Sin.2012, 33 (10), 1217–1245.
(36) Hjortness, M. K.; Riccardi, L.; Hongdusit, A.; Ruppe, A.; Zhao, M.; Kim, E. Y.; Zwart, P. H.; Sankaran, B.; Arthanari, H.; Sousa, M. C.; et al. Abietane-Type Diterpenoids Inhibit Protein Tyrosine Phosphatases by Stabilizing an Inactive Enzyme Conformation. Biochemistry2018, 57 (40), 5886–5896.
(37) Christianson, D. W. Structural and Chemical Biology of Terpenoid Cyclases. Chem. Rev.2006, 106 (8), 3412–3442.
(38) Newman, D. J.; Cragg, G. M. Natural Products as Sources of New Drugs from 1981 to 2014. Journal of Natural Products. 2016, pp 629–661.
(39) Dietrich, J. A.; Yoshikuni, Y.; Fisher, K. J.; Woolard, F. X.; Ockey, D.; McPhee, D. J.; Renninger, N. S.; Chang, M. C. Y.; Baker, D.; Keasling, J. D. A Novel Semi-Biosynthetic Route for Artemisinin Production Using Engineered Substrate-Promiscuous P450BM3. ACS Chem. Biol.2009, 4 (4), 261–267.
(40) Mafu, S.; Jia, M.; Zi, J.; Morrone, D.; Wu, Y.; Xu, M.; Hillwig, M. L.; Peters, R. J. Probing the Promiscuity of Ent -Kaurene Oxidases via Combinatorial Biosynthesis. Proc. Natl. Acad. Sci.2016, 113 (9), 2526–2531.
(41) Martin, V. J. J.; Pitera, D. J.; Withers, S. T.; Newman, J. D.; Keasling, J. D. Engineering a Mevalonate Pathway in Escherichia Coli for Production of Terpenoids. Nat. Biotechnol.2003, 21 (7), 796–802.
(42) Morrone, D.; Lowry, L.; Determan, M. K.; Hershey, D. M.; Xu, M.; Peters, R. J. Increasing Diterpene Yield with a Modular Metabolic Engineering System in E. Coli: Comparison of MEV and MEP Isoprenoid Precursor Pathway Engineering. Appl. Microbiol. Biotechnol.2010, 85 (6), 1893–1906.
(43) Williams, D. C.; Wildung, M. R.; Jin, A. Q.; Dalal, D.; Oliver, J. S.; Coates, R. M.; Croteau, R. Heterologous Expression and Characterization of a “pseudomature” Form of Taxadiene Synthase Involved in Paclitaxel (Taxol) Biosynthesis and Evaluation of a Potential Intermediate and Inhibitors of the Multistep Diterpene Cyclization Reaction. Arch. Biochem. Biophys.2000, 379 (1), 137–146.
(44) Yoshikuni, Y.; Ferrin, T. E.; Keasling, J. D. Designed Divergent Evolution of Enzyme Function. Nature2006, 440, 1078–1082.
(45) Peralta-Yahya, P. P.; Ouellet, M.; Chan, R.; Mukhopadhyay, A.; Keasling, J. D.; Lee, T. S. Identification and Microbial Production of a Terpene-Based Advanced Biofuel. Nat. Commun.2011, 2 (1).
(46) Wiesmann, C.; Barr, K. J.; Kung, J.; Zhu, J.; Erlanson, D. A.; Shen, W.; Fahr, B. J.; Zhong, M.; Taylor, L.; Randal, M.; et al. Allosteric Inhibition of Protein Tyrosine Phosphatase 1B. Nat. Struct. Mol. Biol.2004, 11 (8), 730–737.
(47) Zhang, C.; Chen, X.; Stephanopoulos, G.; Too, H. P. Efflux Transporter Engineering Markedly Improves Amorphadiene Production in Escherichia Coli. Biotechnol. Bioeng.2016, 113 (8), 1755–1763.
(48) Wiesmann, C.; Barr, K. J.; Kung, J.; Zhu, J.; Erlanson, D. A.; Shen, W.; Fahr, B. J.; Zhong, M.; Taylor, L.; Randal, M.; et al. Allosteric Inhibition of Protein Tyrosine Phosphatase 1B. Nat. Struct. Mol. Biol.2004, 11, 730–737.
(49) Keedy, D. A.; Hill, Z. B.; Biel, J. T.; Kang, E.; Rettenmaier, T. J.; Brandao-Neto, J.; Pearce, N. M.; Delft, F. von; Wells, J. A.; Fraser, J. S. An Expanded Allosteric Network in PTP1B by Multitemperature Crystallography, Fragment Screening, and Covalent Tethering. Elife2018, 7 (e36307), doi: 10.7554/eLife.36307.
(50) Vallurupalli, P.; Bouvignies, G.; Kay, L. E. Studying “Invisible” Excited Protein States in Slow Exchange with a Major State Conformation. J. Am. Chem. Soc.2012, 134 (19), 8148–8161.
(51) Amamuddy, O. S.; Veldman, W.; Manyumwa, C.; Khairallah, A.; Agajanian, S.; Oluyemi, O.; Verkhivker, G. M.; Bishop, Ö. T. Integrated Computational Approaches and Tools for Allosteric Drug Discovery. Int. J. Mol. Sci.2020, 21 (3), 847.
(52) Brandt, T.; Holzmann, N.; Muley, L.; Khayat, M.; Wegscheid-Gerlach, C.; Baum, B.; Heine, A.; Hangauer, D.; Klebe, G. Congeneric but Still Distinct: How Closely Related Trypsin Ligands Exhibit Different Thermodynamic and Structural Properties. J. Mol. Biol.2011, 405 (5), 1170–1187.
(53) PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis - PubMed https://pubmed.ncbi.nlm.nih.gov/22404968/ (accessed Jan 17, 2021).
(54) Shimada, T.; Yamazaki, H.; Foroozesh, M.; Hopkins, N. E.; Alworth, W. L.; Guengerich, F. P. Selectivity of Polycyclic Inhibitors for Human Cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol.1998, 11 (9), 1048–1056.
(55) Goldstein, B. J.; Bittner-Kowalczyk, A.; White, M. F.; Harbeck, M. Tyrosine Dephosphorylation and Deactivation of Insulin Receptor Substrate-1 by Protein-Tyrosine Phosphatase 1B. Possible Facilitation by the Formation of a Ternary Complex with the GRB2 Adaptor Protein. J. Biol. Chem.2000, 275, 4283–4289.
(56) Choi, E.; Kikuchi, S.; Gao, H.; Brodzik, K.; Nassour, I.; Yopp, A.; Singal, A. G.; Zhu, H.; Yu, H. Mitotic Regulators and the SHP2-MAPK Pathway Promote IR Endocytosis and Feedback Regulation of Insulin Signaling. Nat. Commun.2019, 10 (1473).
(57) Dubois, M. J.; Bergeron, S.; Kim, H. J.; Dombrowski, L.; Perreault, M.; Fournès, B.; Faure, R.; Olivier, M.; Beauchemin, N.; Shulman, G. I.; et al. The SHP-1 Protein Tyrosine Phosphatase Negatively Modulates Glucose Homeostasis. Nat. Med.2006, 12 (5), 549–556.
(58) Hubert, J.; Nuzillard, J. M.; Renault, J. H. Dereplication Strategies in Natural Product Research: How Many Tools and Methodologies behind the Same Concept? Phytochemistry Reviews. 2017, pp 55–95.
(59) Manguso, R. T.; Pope, H. W.; Zimmer, M. D.; Brown, F. D.; Yates, K. B.; Miller, B. C.; Collins, N. B.; Bi, K.; La Fleur, M. W.; Juneja, V. R.; et al. In Vivo CRISPR Screening Identifies Ptpn2 as a Cancer Immunotherapy Target. Nature2017, 547, 413–418.
(60) Varone, A.; Spano, D.; Corda, D. Shp1 in Solid Cancers and Their Therapy. Frontiers in Oncology. 2020, p 935.
(61) Yang, C. F.; Chen, Y. Y.; Singh, J. P.; Hsu, S. F.; Liu, Y. W.; Yang, C. Y.; Chang, C. W.; Chen, S. N.; Shih, R. H.; Hsu, S. T. D.; et al. Targeting Protein Tyrosine Phosphatase PTP-PEST (PTPN12) for Therapeutic Intervention in Acute Myocardial Infarction. Cardiovasc. Res.2020, 116 (5), 1032–1046.
(62) Li, H.; Yang, F.; Liu, C.; Xiao, P.; Xu, Y.; Liang, Z.; Liu, C.; Wang, H.; Wang, W.; Zheng, W.; et al. Crystal Structure and Substrate Specificity of PTPN12. Cell Rep.2016, 15 (6), 1345–1358.
(63) Paling, N. R. D.; Welham, M. J. Role of the Protein Tyrosine Phosphatase SHP-1 (Src Homology Phosphatase-1) in the Regulation of Interleukin-3-Induced Survival, Proliferation and Signalling. Biochem. J.2002, 368 (3), 885–894.
(64) Van Vliet, C.; Bukczynska, P. E.; Puryer, M. A.; Sadek, C. M.; Shields, B. J.; Tremblay, M. L.; Tiganis, T. Selective Regulation of Tumor Necrosis Factor-Induced Erk Signaling by Src Family Kinases and the T Cell Protein Tyrosine Phosphatase. Nat. Immunol.2005, 6 (3), 253–260.
(65) Zhang, S.; Zhang, Z. Y. PTP1B as a Drug Target: Recent Developments in PTP1B Inhibitor Discovery. Drug Discov. Today2007, 12, 373–381.
(66) Oleinikovas, V.; Saladino, G.; Cossins, B. P.; Gervasio, F. L. Understanding Cryptic Pocket Formation in Protein Targets by Enhanced Sampling Simulations. J. Am. Chem. Soc.2016, 138 (43), 14257–14263.
(67) Rutledge, P. J.; Challis, G. L. Discovery of Microbial Natural Products by Activation of Silent Biosynthetic Gene Clusters. Nature Reviews Microbiology. 2015, pp 509–523.
(68) Hartenfeller, M.; Schneider, G. De Novo Drug Design. In Chemoinformatics and Computational Chemical Biology; Bajorath, J., Ed.; Humana Press: Totowa, NJ, 2011; pp 299–323.
(69) Packer, M. S.; Liu, D. R. Methods for the Directed Evolution of Proteins. Nat. Rev. Genet.2015, 16 (7), 379–394.
(70) Johnston, C. W.; Badran, A. H.; Collins, J. J. Continuous Bioactivity-Dependent Evolution of an Antibiotic Biosynthetic Pathway. Nat. Commun.2020, 11, 4202.
(71) Chen, M. J.; Dixon, J. E.; Manning, G. Genomics and Evolution of Protein Phosphatases. Sci. Signal.2017, 10 (474), 1–17.
(72) Carlson, J. C.; Badran, A. H.; Guggiana-Nilo, D. A.; Liu, D. R. Negative Selection and Stringency Modulation in Phage-Assisted Continuous Evolution. Nat. Chem. Biol.2014, 10 (3), 216–222.
(73) Hjortness, M. K.; Riccardi, L.; Hongdusit, A.; Zwart, P. H.; Sankaran, B.; Vivo, M. De; Fox, J. M.; De Vivo, M.; Fox, J. M.; Vivo, M. De; et al. Evolutionarily Conserved Allosteric Communication in Protein Tyrosine Phosphatases. Biochemistry2018, 57 (45), 6443–6451.
(74) Chen, X.; Zhang, C.; Zou, R.; Zhou, K.; Stephanopoulos, G.; Too, H. P. Statistical Experimental Design Guided Optimization of a One-Pot Biphasic Multienzyme Total Synthesis of Amorpha-4,11-Diene. PLoS One2013, 8 (11), e79650.
(75) Edgar, S.; Zhou, K.; Qiao, K.; King, J. R.; Simpson, J. H.; Stephanopoulos, G. Mechanistic Insights into Taxadiene Epoxidation by Taxadiene-5α-Hydroxylase. ACS Chem. Biol.2016, 11 (2), 460–469.
(76) UniProt Consortium. UniProt.org.
(77) Price, M. N.; Dehal, P. S.; Arkin, A. P. FastTree 2 - Approximately Maximum-Likelihood Trees for Large Alignments. PLoS One2010, 5 (3), e9490.
(78) Yu, G.; Smith, D. K.; Zhu, H.; Guan, Y.; Lam, T. T. Y. Ggtree: An r Package for Visualization and Annotation of Phylogenetic Trees with Their Covariates and Other Associated Data. Methods Ecol. Evol.2017, 8 (1), 28–36.
(79) Burnham, K. P.; Anderson, D. R. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach, 2nd Edn. Springer-Verlag, New York; 2002; Vol. 60.
(80) Winter, G. Xia2: An Expert System for Macromolecular Crystallography Data Reduction. J. Appl. Crystallogr.2010, 43 (1), 186–190.
(81) Afonine, P. V; Grosse-Kunstleve, R. W.; Echols, N.; Headd, J. J.; Moriarty, N. W.; Mustyakimov, M.; Terwilliger, T. C.; Urzhumtsev, A.; Zwart, P. H.; Adams, P. D. Towards Automated Crystallographic Structure Refinement with Phenix.Refine. Acta Crystallogr. D. Biol. Crystallogr.2012, 68 (Pt 4), 352–367.
(82) Emsley, P.; Cowtan, K. Coot: Model-Building Tools for Molecular Graphics. Acta Crystallogr. Sect. D Biol. Crystallogr.2004, 60 (12 I), 2126–2132.
(83) Joosten, R. P.; Long, F.; Murshudov, G. N.; Perrakis, A. The PDB_REDO Server for Macromolecular Structure Model Optimization. IUCrJ2014, 1 (4), 213–220.
(84) Vitalis, A.; Pappu, R. V. Chapter 3 Methods for Monte Carlo Simulations of Biomacromolecules; Wheeler, R. A. B. T.-A. R. in C. C., Ed.; Elsevier, 2009; Vol. 5, pp 49–76.
(85) Vitalis, A.; Pappu, R. V. ABSINTH: A New Continuum Solvation Model for Simulations of Polypeptides in Aqueous Solutions. J. Comput. Chem.2009, 30 (5), 673–699.
(86) Choi, J.-M.; Pappu, R. V. Improvements to the ABSINTH Force Field for Proteins Based on Experimentally Derived Amino Acid Specific Backbone Conformational Statistics. J. Chem. Theory Comput.2019, 15 (2), 1367–1382.
(87) Abraham, M. J.; Murtola, T.; Schulz, R.; Páll, S.; Smith, J. C.; Hess, B.; Lindah, E. Gromacs: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers. SoftwareX2015, 1 (2), 19–25.
(88) Huang, J.; Rauscher, S.; Nawrocki, G.; Ran, T.; Feig, M.; De Groot, B. L.; Grubmüller, H.; MacKerell, A. D. CHARMM36m: An Improved Force Field for Folded and Intrinsically Disordered Proteins. Nat. Methods2016, 14 (71–73), 71–73.
(89) MacKerell, A. D.; Bashford, D.; Bellott, M.; Dunbrack, R. L.; Evanseck, J. D.; Field, M. J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S.; et al. All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins. J. Phys. Chem. B1998, 102 (18), 3586–3616.
(90) Vanommeslaeghe, K.; Hatcher, E.; Acharya, C.; Kundu, S.; Zhong, S.; Shim, J.; Darian, E.; Guvench, O.; Lopes, P.; Vorobyov, I.; et al. CHARMM General Force Field: A Force Field for Drug-like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields. J. Comput. Chem.2010, 31 (4), 671–690.
(91) Yu, W.; He, X.; Vanommeslaeghe, K.; MacKerell, A. D. Extension of the CHARMM General Force Field to Sulfonyl-Containing Compounds and Its Utility in Biomolecular Simulations. J. Comput. Chem.2012, 33 (31), 2451–2468.
(92) Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. G. E. M. LINCS: A Linear Constraint Solver for Molecular Simulations. J. Comput. Chem.1997, 18 (12), 1463–1472.
(93) Darden, T.; York, D.; Pedersen, L. Particle Mesh Ewald: An N·log(N) Method for Ewald Sums in Large Systems. J. Chem. Phys.1993, 98 (12), 10089.
(94) Bussi, G.; Donadio, D.; Parrinello, M. Canonical Sampling through Velocity Rescaling. J. Chem. Phys.2007, 126, 014101.
(95) Parrinello, M. Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method. J. Appl. Phys.1981, 52 (12), 7182.
(96) Rice, P.; Longden, L.; Bleasby, A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet.2000, 16 (6), 276–277.